|
Feb 20
|
FTC case against Caremark, Express Scripts, Optum Rx can move forward, judge rules
|
|
Feb 19
|
Community Health Q4 Earnings Miss on Lower Adjusted Admissions
|
|
Feb 19
|
Inside Trump’s Million-Dollar Dinners With Healthcare Executives
|
|
Feb 18
|
White House targets PBM reform as drug pricing concerns escalate
|
|
Feb 18
|
Pediatrix Medical Gears Up for Q4 Results: What to Expect?
|
|
Feb 17
|
1 Healthcare Stock Primed for Growth and 2 to Avoid
|
|
Feb 17
|
1 Healthcare Stock Primed for Growth and 2 to Snub
|
|
Jan 2
|
Are The Cigna Group's (NYSE:CI) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?
|
|
Dec 30
|
Drug Middlemen Spared by Trump and Musk, for Now
|
|
Oct 5
|
The Cigna Group (CI): Diversified Services and Strategic Growth Driving Success
|
|
Oct 5
|
Cigna Corporation (CI): A Buzzing AI Health Stock to Add to Your Portfolio
|
|
Oct 4
|
Is The Cigna Group (NYSE:CI) The Top Goldman Sachs Fund Manager Stock Pick?
|
|
Oct 4
|
Will Cigna (CI) Beat Estimates Again in Its Next Earnings Report?
|
|
Oct 4
|
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
|
|
Oct 4
|
CVS Health upgraded at TD Cowen after insurer unveils 2025 Medicare Advantage plan
|
|
Oct 4
|
Texas sues major PBMs, pharma companies over high insulin prices
|
|
Oct 3
|
Texas Attorney General Sues Insulin Manufacturers and Pharmacy Benefit Managers Over Price-Fixing Conspiracy That Increased Prices by 1,000%
|
|
Oct 3
|
The Cigna Group's Third Quarter 2024 Earnings Release Details
|
|
Oct 2
|
Heard on the Street: Humana Could Plunge Into Cigna’s Arms
|
|
Oct 2
|
Blue Shield of California sidesteps PBMs with new Humira biosimilar deal
|